“CMS Administrator Seema Verma said Wednesday there need to be “serious discussions” on how to pay for new and extremely pricey drug innovations but slammed the idea of giving Medicare negotiating power.”
“Verma told reporters that Medicare and Medicaid’s payment systems were not expected to deal with high costs for new and curative innovations.”
“Verma did not endorse a specific idea on how to address these high price tags, saying that she wants to tap researchers from the outside.”
“She floated the idea of value-based or outcome-based payments for drug therapies, where patients would pay for treatments that work and potentially get a rebate if it fails…” Read the full article here.
Source: Verma exploring outcome-based ideas to tackle high drug costs – By Robert King, May 22, 2019. Modern Healthcare.
